Prozone effect of serum IgE levels in a case of plasma cell leukemia

Giampaolo Talamo1, William Castellani, Nathan G Dolloff

  • 1Penn State Hershey Cancer Institute, 500 University Drive, Hershey, PA 17033, USA. gtalamo@hmc.psu.edu

Insights

This case study highlights a rare IgE-kappa multiple myeloma with secondary plasma cell leukemia. The prozone effect complicated monitoring, emphasizing the need for careful interpretation of tumor markers.

Area of Science:

  • Hematology
  • Clinical Chemistry
  • Immunology

Background:

  • Multiple myeloma (MM) is a plasma cell malignancy.
  • Secondary plasma cell leukemia (PCL) is a rare, aggressive complication of MM.
  • IgE-producing plasma cell neoplasms are exceptionally rare.

Observation:

  • A unique case of MM with secondary PCL secreting IgE-kappa immunoglobulin is presented.
  • Standard tumor markers like serum free light chains and Bence-Jones proteinuria were uninformative.
  • Quantitative serum IgE levels yielded inaccurate results due to the prozone effect.

Findings:

  • The prozone effect, caused by antigen excess, interfered with IgE detection methods.
  • The M component measured by serum protein electrophoresis (SPEP) was the sole reliable marker for therapeutic response.
  • Accurate interpretation of tumor markers is crucial for managing rare IgE-producing PCL.

Implications:

  • Clinicians must be aware of the prozone effect and its potential to mask disease progression.
  • Alternative or modified laboratory methods may be needed for accurate monitoring of IgE-secreting neoplasms.
  • This case underscores the heterogeneity of plasma cell disorders and challenges in their laboratory assessment.